Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending October 29, 2012. The report details a specific share repurchase transaction executed under authority granted by shareholders at the Annual General Meeting on May 3, 2012.
Key Financial Metrics and Capital Structure
The filing focuses on treasury share holdings and capital structure rather than operational financial performance metrics such as revenue or profit.
- Shares Repurchased: 1,000,000 Ordinary Shares of 25 pence each.
- Repurchase Price Range: Highest price paid was 1,415 pence per share; lowest price paid was 1,402.5 pence per share.
- Treasury Shares Held: 514,190,427 shares (9.44% of total issued share capital).
- Treasury Shares (Including Unsettled): 517,290,427 shares (10.49% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,931,129,934 shares.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,000,000 shares on October 29, 2012. Consequently, the total number of shares held in Treasury increased, raising the percentage of total voting rights held in Treasury to 10.49% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares in issue (4,931,129,934) for calculating disclosure thresholds under FSA rules.
- Confirm the updated Treasury share count (514,190,427 settled) and its impact on the total issued share capital percentage (9.44%).
- Review the specific price range paid (1,402.5 to 1,415 pence) against market prices on October 29, 2012.
- Check the status of unsettled shares to understand the 10.49% voting rights figure.